149 related articles for article (PubMed ID: 38335400)
1. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome.
Tan Y; Zhou X
Medicine (Baltimore); 2024 Feb; 103(6):e35914. PubMed ID: 38335400
[TBL] [Abstract][Full Text] [Related]
2. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.
Ou P; Liu X; Tang Z; Hou Z; Liu L; Liu J; Zhou S; Fang Z; Sun K; Chen Y; Chen X; Li Y; Chen J
Curr Pharm Des; 2019; 25(35):3762-3768. PubMed ID: 31589115
[TBL] [Abstract][Full Text] [Related]
3. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
[TBL] [Abstract][Full Text] [Related]
4. Tusanqi and hepatic sinusoidal obstruction syndrome.
Wang JY; Gao H
J Dig Dis; 2014 Mar; 15(3):105-7. PubMed ID: 24528632
[TBL] [Abstract][Full Text] [Related]
5. Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report.
Zheng Q; Zhang H
Medicine (Baltimore); 2024 Mar; 103(11):e37341. PubMed ID: 38489699
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study.
Wang Y; Qiao D; Li Y; Xu F
BMC Gastroenterol; 2018 Oct; 18(1):156. PubMed ID: 30367628
[TBL] [Abstract][Full Text] [Related]
7. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yao J; Wu J; Jia S; Shao J; Zhang X; Xu Z; Zhang H; Li H; Yao X
J Clin Lab Anal; 2022 Dec; 36(12):e24793. PubMed ID: 36447383
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yu XZ; Ji T; Bai XL; Liang L; Wang LY; Chen W; Liang TB
J Zhejiang Univ Sci B; 2013 Jan; 14(1):68-75. PubMed ID: 23303633
[TBL] [Abstract][Full Text] [Related]
9. Hepatic sinusoidal obstruction syndrome caused by the ingestion of
Cen P; Ding J; Jin J
J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.
Kan X; Ye J; Rong X; Lu Z; Li X; Wang Y; Yang L; Xu K; Song Y; Hou X
Sci Rep; 2016 Nov; 6():37998. PubMed ID: 27897243
[TBL] [Abstract][Full Text] [Related]
11. The effect of Salvia miltiorrhiza in a mouse model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yang L; Huo JR; Zhu HY; Chen Z; Wang XY
Rev Esp Enferm Dig; 2019 Nov; 111(11):823-827. PubMed ID: 31566407
[TBL] [Abstract][Full Text] [Related]
12. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.
Li S; Li Y; Zhou C; Li H; Chen C; Peng C; Wang T; Liu F; Xiao J; Shi L
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):931-942. PubMed ID: 37225971
[TBL] [Abstract][Full Text] [Related]
13. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.
Zhang F; Zhou Y; Yang X; Xiong AZ; Wang ZT; Yang L
Acta Pharmacol Sin; 2019 Jun; 40(6):781-789. PubMed ID: 30367152
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.
Yang XQ; Ye J; Li X; Li Q; Song YH
World J Gastroenterol; 2019 Jul; 25(28):3753-3763. PubMed ID: 31391770
[TBL] [Abstract][Full Text] [Related]
15. Hepatic veno-occlusive disease related to Gynura segetum: A case report.
Sun Z; Kang J; Zhang Y
Medicine (Baltimore); 2018 Apr; 97(17):e0552. PubMed ID: 29703039
[TBL] [Abstract][Full Text] [Related]
16. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
Gao H; Li N; Wang JY; Zhang SC; Lin G
J Dig Dis; 2012 Jan; 13(1):33-9. PubMed ID: 22188914
[TBL] [Abstract][Full Text] [Related]
17. Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.
Zhang H; Jia S; Jin L; Mb JY; Shen Z; Wu J; Yao X; Chen D; Zhang C; Yu S; Zhu N; Jin L; Yao X
Acta Cir Bras; 2022; 36(11):e361104. PubMed ID: 35195181
[TBL] [Abstract][Full Text] [Related]
18. Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Wang X; Zhang W; Zhang M; Zhang F; Xiao J; Yin Q; Han H; Li T; Lin G; Zhuge Y
Hepatol Int; 2022 Jun; 16(3):669-679. PubMed ID: 35023026
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt.
Xiao J; Tu J; Zhang H; Zhang F; Zhang W; Xu H; Yin Q; Yang J; Han H; Wang Y; Zhang B; Peng C; Zou X; Zhang M; Zhuge Y
Hepatol Int; 2021 Jun; 15(3):720-729. PubMed ID: 33507485
[TBL] [Abstract][Full Text] [Related]
20. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Zhuge Y; Liu Y; Xie W; Zou X; Xu J; Wang J;
J Gastroenterol Hepatol; 2019 Apr; 34(4):634-642. PubMed ID: 30669184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
